Details For Selected Brain Tumor Treatment
Sponsored By
Please Click On The Above Banner For More Details
Braintumor Website

Back to New Treatments List Back to New Treatments List

Treatment Name: Treatment of Primary Glioblastoma Multiforme With Cetuximab (Erbitux), Radiotherapy and Temozolomide (GERT) – Phase I/II Trial
Phase: Phase 1/2
Treatment ID#: 1710        
Age Group: Adults Only
Min Karnofsky Score: 60: Requires occasional assistance but is able to care for most of own needs
Conditions: Prior Surgery is Allowed
Prior Radiation is Not Allowed
Prior Chemotherapy is Not Allowed
Last Updated: 05/04/2006
Tumor Types: Glioblastoma Multiforme
Comments:
Treatment Type: Chemotherapy
Radiation
Less-Toxics
Contact: Daniela Schulz-Ertner MD
University of Heidelberg


Heidelberg, Baden-Württemberg, 69120 Germany
Phone: +49-6221-56 Ext. 8201
Fax:
E-mail: Daniela.Ertner@med.uni-heidelberg.de
Website:
  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is a combination of our internal ID and the official ID for the trial, if any.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE
[Click HERE to open a Printer Friendly Version Of This Page!]

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites